Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.900
+0.110 (3.94%)
Dec 20, 2024, 4:00 PM EST - Market closed
Prime Medicine Employees
Prime Medicine had 234 employees as of December 31, 2023. The number of employees increased by 59 or 33.71% compared to the previous year.
Employees
234
Change (1Y)
59
Growth (1Y)
33.71%
Revenue / Employee
$3,419
Profits / Employee
-$936,962
Market Cap
370.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 234 | 59 | 33.71% |
| Dec 31, 2022 | 175 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ZimVie | 2,600 |
| AngioDynamics | 748 |
| Valneva SE | 676 |
| Kamada | 378 |
| REGENXBIO | 344 |
| Sana Biotechnology | 328 |
| Personalis | 225 |
| Design Therapeutics | 58 |
PRME News
- 25 days ago - Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies - Seeking Alpha
- 4 weeks ago - Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics - GlobeNewsWire
- 6 weeks ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress - GlobeNewsWire
- 2 months ago - Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings - GlobeNewsWire
- 2 months ago - Crude Oil Moves Higher; Prime Medicine Shares Spike Higher - Benzinga
- 2 months ago - Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline - Benzinga
- 2 months ago - Prime Medicine Unveils Strategically Focused Pipeline - GlobeNewsWire